Suppr超能文献

前药策略作为增强药物渗透性的一种方法。

Prodrug Approach as a Strategy to Enhance Drug Permeability.

作者信息

de Souza Mateus Mello, Gini Ana Luísa Rodriguez, Moura Jhonnathan Alves, Scarim Cauê Benito, Chin Chung Man, Dos Santos Jean Leandro

机构信息

School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.

Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-900, SP, Brazil.

出版信息

Pharmaceuticals (Basel). 2025 Feb 21;18(3):297. doi: 10.3390/ph18030297.

Abstract

Absorption and permeability are critical physicochemical parameters that must be balanced to achieve optimal drug uptake. These key factors are closely linked to the maximum absorbable dose required to provide appropriate plasma levels of drugs. Among the various strategies employed to enhance drug solubility and permeability, prodrug design stands out as a highly effective and versatile approach for improving physicochemical properties and enabling the optimization of biopharmaceutical and pharmacokinetic parameters while mitigating adverse effects. Prodrugs are compounds with reduced or no activity that, through bio-reversible chemical or enzymatic processes, release an active parental drug. The application of this technology has led to significant advancements in drug optimization during the design phase, and it offers broad potential for further development. Notably, approximately 13% of the drugs approved by the U.S. Food and Drug Administration (FDA) between 2012 and 2022 were prodrugs. In this review article, we will explore the application of prodrug strategies to enhance permeability, describing examples of market drugs. We also describe the use of the prodrug approach to optimize PROteolysis TArgeting Chimeras (PROTACs) permeability by using conjugation technologies. We will highlight some new technologies in prodrugs to enrich permeability properties, contributing to developing new effective and safe prodrugs.

摘要

吸收和渗透性是关键的物理化学参数,必须加以平衡以实现最佳的药物摄取。这些关键因素与提供适当血浆药物水平所需的最大可吸收剂量密切相关。在用于提高药物溶解度和渗透性的各种策略中,前药设计作为一种提高物理化学性质、优化生物药剂学和药代动力学参数同时减轻不良反应的高效且通用的方法脱颖而出。前药是活性降低或无活性的化合物,它们通过生物可逆的化学或酶促过程释放出活性母体药物。这项技术的应用在设计阶段推动了药物优化的重大进展,并且具有广阔的进一步发展潜力。值得注意的是,2012年至2022年间美国食品药品监督管理局(FDA)批准的药物中约有13%是前药。在这篇综述文章中,我们将探讨前药策略在提高渗透性方面的应用,并介绍市售药物的实例。我们还将描述通过使用偶联技术,利用前药方法优化蛋白酶靶向嵌合体(PROTAC)的渗透性。我们将重点介绍一些在前药方面丰富渗透性的新技术,为开发新的有效且安全的前药做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5b/11946379/4b58917a05c7/pharmaceuticals-18-00297-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验